Axogen, Inc. (AXGN) Guidance & Earnings Results

On 2026-07-29 Axogen, Inc. raised guidance: "FY2026 revenue at least $279M (24% growth), gross margin at least 73%, positive free cash…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AXGNAxogen, Inc.Follow AXGN — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 2.0B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 28 Oct, in 4 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
29 Jul 26	Raised	FY2026 revenue at least $279M (24% growth), gross margin at least 73%, positive free cash flow · full year
28 Apr 26	Raised	Full-year revenue guidance raised to at least $270M (20% growth) · full year
24 Feb 26	Raised	Revenue growth at least 18% to $265.7M; gross margin 74-76% · full year
29 Oct 25	Raised	Revenue guidance raised to at least 19% growth ($222.8M) · full year
5 Aug 25	Raised	FY2025 revenue raised to at least $219M (at least 17% growth); gross margin maintained at 73-75% (includes ~1% one-time cost from BLA approval); net cash flow positive expected for full year · full year

Axogen, Inc. — questions

What guidance did Axogen, Inc. give?: On 2026-07-29: "FY2026 revenue at least $279M (24% growth), gross margin at least 73%, positive free cash flow"
When does Axogen, Inc. report earnings?: Axogen, Inc.'s next earnings report is expected on 2026-10-28.

Every figure on this page comes from Axogen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.